The percentage of CD4+CD25+FOXP3+ Tregs was greater in patients with chronic hepatitis C than in the healthy control subjects and CD4+CD25+FOXP3+ Tregs were able to inhibit the response of CD8+ T lymphocytes to various virus antigens, thus, promoting chronic HCV infection. The gene discussed is CD8A; the disease is chronic hepatitis C virus infection.